KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non Operating Investment Income: 2009-2013

Historic Non Operating Investment Income for Vertex Pharmaceuticals (VRTX) over the last 3 years, with Dec 2013 value amounting to $53.5 million.

  • Vertex Pharmaceuticals' Non Operating Investment Income was N/A to $53.5 million in Q4 2013 from the same period last year, while for Dec 2013 it was $49.9 million, marking a year-over-year change of. This contributed to the annual value of -$16.8 million for FY2011, which is 59.25% up from last year.
  • Vertex Pharmaceuticals' Non Operating Investment Income amounted to $53.5 million in Q4 2013, which was up 1,226.44% from -$4.7 million recorded in Q3 2013.
  • Vertex Pharmaceuticals' Non Operating Investment Income's 5-year high stood at $53.5 million during Q4 2013, with a 5-year trough of -$27.2 million in Q2 2010.
  • Moreover, its 2-year median value for Non Operating Investment Income was -$868,000 (2011), whereas its average is $5.1 million.
  • Within the past 5 years, the most significant YoY rise in Vertex Pharmaceuticals' Non Operating Investment Income was 86.84% (2011), while the steepest drop was 275.96% (2011).
  • Over the past 4 years, Vertex Pharmaceuticals' Non Operating Investment Income (Quarterly) stood at -$1.8 million in 2009, then plummeted by 257.07% to -$6.6 million in 2010, then spiked by 86.84% to -$868,000 in 2011, then reached $53.5 million in 2013.
  • Its Non Operating Investment Income was $53.5 million in Q4 2013, compared to -$4.7 million in Q3 2013 and $27,000 in Q2 2013.